Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Allscripts announces first quarter 2018 results
May 3, 2018 4:02 PM EDTReported first quarter growth of 24% in GAAP revenue to $514 million, 25% in non-GAAP revenue to $519 million; First quarter GAAP EPS of ($0.22) reflecting acquisition transaction fees, growth of 23% in non-GAAP EPS to $0.16Delivered record first quarter bookings of $304 millionAnnounced agreement to acquire HealthGrid to expand FollowMyHealth® patient engagement platform
CHICAGO, May 03, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2018.
First... More
